WT1, NY-ESO-1 AND PRAME EXPRESSION IN BREAST CANCER SUBTYPES

被引：2
|
作者：
Esposito, A. [1 ]
Bagnardi, V. [2 ]
Criscitiello, C. [1 ]
Gelao, L. [1 ]
Viale, G. [3 ]
Curigliano, G. [1 ]
机构：
[1] European Inst Oncol, Early Drug Dev Innovat Therapy Div, Milan, Italy
[2] Univ Milano Bicocca, Div Epidemiol & Biostat, Dept Stat & Quantitat Methods, Ist Europeo Oncol, Milan, Italy
[3] Univ Milan, Sch Med, Div Pathol, Ist Europeo Oncol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu067.6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
54P
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [21] PROGNOSTIC VALUE OF MAGE-A AND NY-ESO-1 EXPRESSION IN PHARYNGEAL CANCER
    Pastorcic-Grgic, Marija
    Sarcevic, Bozena
    Dosen, Danijel
    Juretic, Antonio
    Spagnoli, Giulio C.
    Grgic, Marko
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (09): : 1178 - 1184
  • [22] NY-ESO-1 and clinicopathological features in ovarian cancer
    Topka, Charlotte R.
    ElMasri, Wafic M.
    Magyar, Clara E.
    Song, Min
    Dorigo, Oliver
    CANCER RESEARCH, 2012, 72
  • [23] The role of the NY-ESO-1 in the prognosis of gastric cancer
    Misir, Zvonimir
    Glavcic, Goran
    Jankovic, Suzana
    Kruljac, Ivan
    Cugura-Filipovic, Jaksa
    Cimiimic, Kristina
    Ulamec, Monika
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (04): : 813 - 820
  • [24] Cancer stem-like cells with increased expression of NY-ESO-1 initiate breast cancer metastasis
    Liu, Mai-Ying
    Su, Hang
    Huang, Hua-Lan
    Chen, Jing-Qi
    ONCOLOGY LETTERS, 2019, 18 (04) : 3664 - 3672
  • [25] Expression of PD-L1 and NY-ESO-1 in early and advanced triple-negative breast cancer
    Tessari, Anna
    Paolini, Biagio
    Mariani, Luigi
    Pilla, Lorenzo
    Carcangiu, Maria Luisa
    Moliterni, Angela
    De Braud, Filippo G.
    Cresta, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma
    Dufresne, A.
    Pokras, S.
    Meurgey, A.
    Chabaud, S.
    Toulmonde, M.
    Bompas, E.
    Le Cesne, A.
    Robin, Y. -M
    Duffaud, F.
    Valentin, T.
    El Zein, S.
    Leroux, A.
    Dubray-Longeras, P.
    Firmin, N.
    de Pinieux, G.
    Noal, S.
    Delfour, C.
    Bollard, J.
    Tonon, L.
    Biette, A.
    Gadot, N.
    Attignon, V.
    Jean-Denis, M.
    Woessner, M.
    Klohe, E.
    Thayaparan, T.
    Eleftheriadou, I.
    Blouch, K.
    Nathenson, M. J.
    Blay, J. -y.
    ESMO OPEN, 2024, 9 (08)
  • [27] NY-ESO-1 protein expression and humoral immune responses in prostate cancer
    Fosså, A
    Berner, A
    Fosså, SD
    Hernes, E
    Gaudernack, G
    Smeland, EB
    PROSTATE, 2004, 59 (04): : 440 - 447
  • [28] NY-ESO-1 Expression Is Associated with Melanoma Thickness, but Not Mortality
    Giavina-Bianchi, Mara
    Sotto, Miriam Nacagamo
    Kanashiro, Luciane
    Simpson, Andrew J.
    Giavina-Bianchi, Pedro
    Kalil, Jorge
    Festa, Cyro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB66 - AB66
  • [29] NY-ESO-1 is associated with an aggressive phenotype of ovarian cancer
    Szender, J. B.
    Papanicolau-Sengos, A.
    Eng, K.
    Miliotto, A. J.
    Lugade, A.
    Gnjatic, S.
    Matsuzaki, J.
    Odunsi, K.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 30 - 30
  • [30] NY-ESO-1 antigen: A promising frontier in cancer immunotherapy
    Alsalloum, Alaa
    Shevchenko, Julia A.
    Sennikov, Sergey
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (09):
12345